[Efficacy, safety, and cost-effectiveness of meningococcal vaccines].

Abstract

Meningococcal meningitis is an acute, severe respiratory infectious disease caused by Neisseria meningitidis. Immunization with meningococcal vaccine is the most effective measure to control and prevent transmission of meningococcal meningitis. Meningococcal vaccines in the Chinese market include meningococcal polysaccharide vaccine, meningococcal polysaccharide conjugate vaccine, and a combined vaccine containing meningococcal polysaccharide conjugate vaccine. This article reviews research progress on the efficacy, safety, and cost-effectiveness of meningococcal vaccines, particularly in the Chinese market, to support appropriate use of the various meningococcal vaccines for preventing meningococcal meningitis.

• Authors: Chinese Preventive Medicine Association
• Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi (Zhonghua Liu Xing Bing Xue Za Zhi) Vol. 40 Issue 2 Pg. 129-135 (Feb 10 2019) ISSN: 0254-6450 [Print] China
• PMID: 30744260 (Publication Type: Journal Article, Review)

Chemical References

• Meningococcal Vaccines
• Vaccines, Conjugate

Topics

• Cost-Benefit Analysis
• Humans
• Immunization (economics)
• Meningitis, Meningococcal (prevention & control)
• Meningococcal Vaccines (administration & dosage, adverse effects, economics, immunology)
• Vaccination (economics)
• Vaccines, Conjugate (administration & dosage, adverse effects, immunology)